Clinical Trial Update: Inhaled Budesonide for Altitude Illness Prevention [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating inhaled budesonide for preventing altitude sickness was withdrawn before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Altitude Sickness

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Altitude Sickness | Phase 3 | Status: WITHDRAWN